Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × High-Energy Shock Waves × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Prostatic Neoplasms 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Hairy Cell 1 Ganglioneuroblastoma 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Agnosia 1 Adenocarcinoma, Follicular 1

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡